Laurent Chardonnet - May 23, 2023 Form 4 Insider Report for Prelude Therapeutics Inc (PRLD)

Role
Chief Financial Officer
Signature
/s/ Bryant D. Lim, as Attorney-in-Fact
Stock symbol
PRLD
Transactions as of
May 23, 2023
Transactions value $
$27,500
Form type
4
Date filed
5/25/2023, 04:05 PM
Previous filing
Feb 9, 2023
Next filing
Mar 4, 2024

Transactions Table

Type Sym Class Transaction Value $ Shares Change % * Price $ Shares After Date Ownership Footnotes
transaction PRLD Common Stock Purchase $27.5K +5K +13.45% $5.50 42.2K May 23, 2023 Direct F1
* An asterisk sign (*) next to the price indicates that the price is likely invalid.

Explanation of Responses:

Id Content
F1 The reported total includes 1,292 shares of common stock the reporting person has acquired since the date of his last ownership report through the issuer's Employee Stock Purchase Plan in one or more transactions exempt pursuant to Rules 16b-3(c).